Open Access

Surgical treatment of early tongue squamous cell carcinoma and patient survival

  • Authors:
    • Lansheng Zhu
    • Yanling Wang
    • Rui Li
    • Aiqun Liu
    • Xiaoping Zhang
    • Chunran Zuo
    • Xiaoting Xu
  • View Affiliations

  • Published online on: April 18, 2019     https://doi.org/10.3892/ol.2019.10271
  • Pages: 5681-5685
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Surgical options for treating early tongue squamous cell carcinoma and patient survival were explored. Clinical records of 128 patients with early tongue squamous cell carcinoma who were treated in Henan Province Hospital of TCM from June, 2010 to June, 2013 were retrospectively analyzed. According to adopted treatment plan, the patients were divided into 3 groups: 42 patients in surgical therapy alone group, 46 patients in preoperative radiotherapy group, and 40 patients in postoperative radiotherapy group. Statistical analysis was performed on the general data of patients and clinical records, as well as the 5‑year survival rate and recurrence rate. The overall 5‑year survival rate for all patients was 86.7% (111/128), and the 5‑year disease‑specific survival rate was 88.8% (111/125). In the individual groups, the 5‑year survival rate and the 5‑year disease‑specific survival rate were 91.3% (84/92) and 91.3% (84/92), respectively, in the surgical therapy alone group 76.9% (10/13) and 83.3% (10/12), respectively, in the preoperative radiotherapy group, and 73.9% (17/23) and 81.0% (17/21), respectively, in the postoperative radiotherapy group. There were no statistically significant differences in 5‑year survival rate (χ2=5.990, P=0.051) and 5‑year disease‑specific survival rate (χ2=2.223, P=0.329) among the three groups. In total, there were 25 cases of recurrence during follow‑up. The recurrence rate was 19.5%; the local recurrence rate was 11.7% (15/128); and the regional recurrence rate was 7.8% (10/128). There were 6 cases of metastasis, and the metastatic rate was 4.7%. There were no statistically significant differences in recurrence rate and metastatic rate among the three groups. Compared with surgical therapy alone, radiotherapy combined with surgical therapy neither improved 5‑year survival rate nor reduced recurrence rate. Therefore, surgical therapy alone is suggested to be the preferred option for treating early tongue squamous cell carcinoma.

References

1 

Kelner N, Rodrigues PC, Bufalino A, Fonseca FP, Santos-Silva AR, Miguel MC, Pinto CA, Leme AF, Graner E, Salo T, et al: Activin A immunoexpression as predictor of occult lymph node metastasis and overall survival in oral tongue squamous cell carcinoma. Head Neck. 37:479–486. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Aparna M, Rao L, Kunhikatta V and Radhakrishnan R: The role of MMP-2 and MMP-9 as prognostic markers in the early stages of tongue squamous cell carcinoma. J Oral Pathol Med. 44:345–352. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Maxwell JH, Thompson LD, Brandwein-Gensler MS, Weiss BG, Canis M, Purgina B, Prabhu AV, Lai C, Shuai Y, Carroll WR, et al: Early oral tongue squamous cell carcinoma: Sampling of margins from tumor bed and worse local control. JAMA Otolaryngol Head Neck Surg. 141:1104–1110. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Thiagarajan S, Nair S, Nair D, Chaturvedi P, Kane SV, Agarwal JP and D'Cruz AK: Predictors of prognosis for squamous cell carcinoma of oral tongue. J Surg Oncol. 109:639–644. 2014. View Article : Google Scholar : PubMed/NCBI

5 

Ren ZH, Wu HJ, Zhang S, Wang K, Gong ZJ, He ZJ and Peng J: A new surgical strategy for treatment of tongue squamous cell carcinoma based on anatomic study with preliminary clinical evaluation. J Craniomaxillofac Surg. 43:1577–1582. 2015. View Article : Google Scholar : PubMed/NCBI

6 

Janakiraman H, House RP, Talwar S, Courtney SM, Hazard ES, Hardiman G, Mehrotra S, Howe PH, Gangaraju V and Palanisamy V: Repression of caspase-3 and RNA-binding protein HuR cleavage by cyclooxygenase-2 promotes drug resistance in oral squamous cell carcinoma. Oncogene. 36:3137–3148. 2017. View Article : Google Scholar : PubMed/NCBI

7 

Abu-Ghanem S, Yehuda M, Carmel NN, Leshno M, Abergel A, Gutfeld O and Fliss DM: Elective neck dissection vs observation in early-stage squamous cell carcinoma of the oral tongue with no clinically apparent lymph node metastasis in the neck: A systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 142:857–865. 2016. View Article : Google Scholar : PubMed/NCBI

8 

Tsushima N, Sakashita T, Homma A, Hatakeyama H, Kano S, Mizumachi T, Kakizaki T, Suzuki T and Fukuda S: The role of prophylactic neck dissection and tumor thickness evaluation for patients with cN0 tongue squamous cell carcinoma. Eur Arch Otorhinolaryngol. 273:3987–3992. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Goepfert RP, Kezirian EJ and Wang SJ: Oral tongue squamous cell carcinoma in young women: A matched comparison - do outcomes justify treatment intensity? ISRN Otolaryngol. 2014:5293952014. View Article : Google Scholar : PubMed/NCBI

10 

Tong XJ, Tang ZG, Shan ZF and Guo XC: The anterolateral thigh flap for soft tissue reconstruction in patients with tongue squamous cell carcinoma. World J Surg Oncol. 14:2132016. View Article : Google Scholar : PubMed/NCBI

11 

Goto M, Hanai N, Ozawa T, Hirakawa H, Suzuki H, Hyodo I, Kodaira T, Ogawa T, Fujimoto Y, Terada A, et al: Prognostic factors and outcomes for salvage surgery in patients with recurrent squamous cell carcinoma of the tongue. Asia Pac J Clin Oncol. 12:e141–e148. 2016. View Article : Google Scholar : PubMed/NCBI

12 

Cohen EE, Karrison TG, Kocherginsky M, Mueller J, Egan R, Huang CH, Brockstein BE, Agulnik MB, Mittal BB, Yunus F, et al: Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer. JClin Oncol. 32:2735–2743. 2014. View Article : Google Scholar

13 

Zhang P, Zhang L, Liu H, Zhao L, Li Y, Shen JX, Liu Q, Liu MZ and Xi M: Clinicopathologic characteristics and prognosis of tongue squamous cell carcinoma in patients with and without a history of radiation for nasopharyngeal carcinoma: A matched Case-Control Study. Cancer Res Treat. 49:695–705. 2017. View Article : Google Scholar : PubMed/NCBI

14 

Sung KW, Kim SM, Myoung H, Kim MJ and Lee JH: The effectiveness of elective neck dissection on early (stage I, II) squamous cell carcinoma of the oral tongue. J Korean Assoc Oral Maxillofac Surg. 43:147–151. 2017. View Article : Google Scholar : PubMed/NCBI

15 

Toporcov TN, Znaor A, Zhang ZF, Yu GP, Winn DM, Wei Q, Vilensky M, Vaughan T, Thomson P, Talamini R, et al: Risk factors for head and neck cancer in young adults: A pooled analysis in the INHANCE consortium. Int J Epidemiol. 44:169–185. 2015. View Article : Google Scholar : PubMed/NCBI

16 

Meng J, Gu QP, Meng QF, Zhang J, Li ZP, Si YM, Guo W and Zhuang QW: Efficacy of nimotuzumab combined with docetaxel-cisplatin-fluorouracil regimen in treatment of advanced oral carcinoma. Cell Biochem Biophys. 68:181–184. 2014. View Article : Google Scholar : PubMed/NCBI

17 

Katz O, Nachalon Y, Hilly O, Shpitzer T, Bachar G, Limon D and Popovtzer A: Radiotherapy in early-stage tongue squamous cell carcinoma with minor adverse features. Head Neck. 39:147–150. 2017. View Article : Google Scholar : PubMed/NCBI

18 

Wu K, Li S and Zhang C: Lymph node transfer characteristics and clinical assessment and treatment of early tongue squamous cell carcinoma. Int J Stomatology. 42:30–47. 2015.

19 

Hakeem AH, Pradhan SA, Kannan R and Tubachi J: Clinical outcome of surgical treatment of T1-2 N0 squamous cell carcinoma of oral tongue with observation for the neck: Analysis of 176 cases. Ann Maxillofac Surg. 6:235–240. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

June 2019
Volume 17 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Zhu, L., Wang, Y., Li, R., Liu, A., Zhang, X., Zuo, C., & Xu, X. (2019). Surgical treatment of early tongue squamous cell carcinoma and patient survival. Oncology Letters, 17, 5681-5685. https://doi.org/10.3892/ol.2019.10271
MLA
Zhu, L., Wang, Y., Li, R., Liu, A., Zhang, X., Zuo, C., Xu, X."Surgical treatment of early tongue squamous cell carcinoma and patient survival". Oncology Letters 17.6 (2019): 5681-5685.
Chicago
Zhu, L., Wang, Y., Li, R., Liu, A., Zhang, X., Zuo, C., Xu, X."Surgical treatment of early tongue squamous cell carcinoma and patient survival". Oncology Letters 17, no. 6 (2019): 5681-5685. https://doi.org/10.3892/ol.2019.10271